ABSTRACT
Phosphogypsum, which contains more than 90% of the calcium sulfate dehydrate (CaSO4 · 2H2O), is a kind of important renewable gypsum resources. Unlike the natural gypsum, however, phosphorus, fluorine, organic matter and other harmful impurities in phosphogypsum limit its practical use. To ascertain the existence form, content and phase distribution of trace fluoride in phosphogypsum has important theoretical values in removing trace fluoride effectively. In this present paper, the main existence form and phase distribution of trace fluoride in phosphogypsum was investigated by the combination of X-ray photoelectron spectroscopy (XPS) and Electron microprobe analysis (EMPA). The results show that trace fluoride phase mainly includes NaF, KF, CaF2, K2SiF6, Na2SiF6, Na3AlF6, K3AlF6, AlF3 · 3H2O, AlF2.3(OH)0.7 · H2O, Ca5(PO4)3F, Ca10(PO4)6F2. Among them, 4.83% of fluorine exists in the form of fluoride (NaF, KF, CaF2); Accordingly, 8.43% in the form of fluoride phosphate (Ca5(PO4)3F, Ca10(PO4)6F2); 12.21% in the form of fluorine aluminate (Na3AlF6, K3AlF6); 41.52% in the form of fluorosilicate (K2SiF6, Na2SiF6); 33.02% in the form of aluminum fluoride with crystal water (AlF3 · 3H2O, AlF2.3(OH)0.7 · H2O). In the analysis of phase constitution for trace elements in solid samples, the method of combining XPS and EMPA has more advantages. This study also provides theoretical basis for the removal of trace fluorine impurity and the effective recovery of fluorine resources.
ABSTRACT
OBJECTIVE: To study the effect and potential mechanism of Modified Cangfu Daotan Decoction (MCDD) on endometrial receptivity in infertility patients with polycystic ovarian syndrome (PCOS). METHODS: Totally 298 women having normal ovulation who underwent artificial insemination were recruited as the control group, and they received no drug therapy. Another 355 infertility patients with PCOS who received ovarian stimulation therapy were recruited as the treatment group. Then they were further assigned to the treatment group I (195 cases) and the treatment group II (160 cases) according to random digit table. Patients in the treatment group I received clomiphene (CC) + human menopause gonadotropin (HMG) +human chorionic gonadotropin (HCG), while those in the treatment group II received CC + HMG + HCG and additionally took modified MCDD. The therapeutic course for all was three menstrual cycles. The pregnancy ratio, the endometrial thickness, and spiral artery pulsatility index (PI), resistance index (RI), and homeostasis model assessment-insulin resistance (HOMA-IR) were measured. Furthermore, the uncoupling protein 2 (UCP2) level was tested by Western blot. RESULTS: Compared with the control group, the endometrial thickness decreased and PI and RI increased in the treatment group I (all P < 0.05). Compared with the treatment group I , the endometrial thickness increased and PI and RI decreased in the treatment group II (all P < 0.05). Compared with before treatment, HOMA-IR levels were significantly decreased in the treatment group II after treatment (P < 0.05). Compared with the control group before treatment, the HOMA-IR level increased in the treatment group I and the treatment group II before treatment (P < 0.05). Compared with the control group after treatment, the HOMA-IR level increased in the treatment group I (P < 0.05). But there was no statistical difference in the post-treatment HOMA-IR level between the control group and the treatment group II (P < 0.05). Compared with the control group, the post-treatment UCP2 level was increased in the treatment group II (P < 0.05). After one year follow-up, the pregnancy rate was 16.1% (48/298) in the control group, 23.1% (37/160) in the treatment group I, and 33.8% (66/195) in the treatment group II. Compared with the control group, the pregnancy rate was significantly increased in the treatment group II (P < 0.05). CONCLUSION: MCDD was found to be capable of increasing the pregnancy rate of infertility patients with PCOS, which might be associated with improving endometrial blood flow and insulin resistance, increasing the UCP2 expression, and finally improving the endometrial receptivity.
Subject(s)
Drugs, Chinese Herbal/pharmacology , Ovulation Induction/methods , Polycystic Ovary Syndrome/drug therapy , Chorionic Gonadotropin , Clomiphene , Drugs, Chinese Herbal/therapeutic use , Female , Gonadotropins , Humans , Infertility , Infertility, Female , Insulin Resistance , Ovulation , Pregnancy , Pregnancy RateABSTRACT
[This corrects the article DOI: 10.3389/fphar.2020.592827.].
ABSTRACT
Polycystic ovary syndrome (PCOS) is an endocrine disease associated with reproduction. The Cuscuta-Salvia formula has been widely used to treat for PCOS in clinic. However, its chemical and pharmacological properties remain unclear. We identified the active components and related targets of Cuscuta-Salvia using UHPLC-ESI-Q-TOF-MS and TCMSP database. Disease targets were obtained from the DisGeNET and GeneCards databases. Subsequently, common targets between Cuscuta-Salvia and PCOS were identified using a Venn diagram. PPI network was established. Core genes were selected using a Cytoscape software plugin. GO and KEGG enrichment analyses were performed for common targets using the "pathview" package in R. Several core targets were verified using molecular and Immunological methods. By combining UHPLC-ESI-Q-TOF-MS with a network pharmacology study, 14 active components and a total of 80 common targets were obtained. Ten core genes were regulated by Cuscuta-Salvia in PCOS, including IL6, AKT1, VEGFA, TP53, TNF, MAPK1, JUN, EGF, CASP3, and EGFR. GO results showed that cellular response to drugs, response to oxygen levels, response lipopolysaccharides, and response to molecule of bacterial origin in BP category; membrane, transcription regulator complex, nuclear chromatin, postsynaptic membrane, and vesicle lumen in CC category; DNA-binding transcription factor binding, RNA polymerase II-specific DNA-binding transcription factor binding, DNA-binding transcription activator activity, RNA polymerase II-specific, DNA-binding transcription activator activity, and cytokine receptor binding in MF terms. The KEGG enrichment pathway was mainly involved in the PI3K - Akt, MAPK, TNF, IL-17 signalling pathways, and in cellular senescence. Furthermore, the results of the experimental study showed that Cuscuta-Salvia ameliorated the pathological changes in the ovaries, liver and adipose tissue. And it improved the expressions of the genes or proteins. Our results demonstrate that Cuscuta-Salvia may provide a novel pharmacological basis in an experimental model of PCOS by regulating gene expression. This study provides a basis for future research and clinical applications.
Subject(s)
Cuscuta , Polycystic Ovary Syndrome , Salvia , Gene Expression Regulation , Network Pharmacology , Polycystic Ovary Syndrome/drug therapy , Polycystic Ovary Syndrome/genetics , Polycystic Ovary Syndrome/metabolismABSTRACT
The crisis of male infertility is an issue of human reproductive health worldwide. The Wuzi Yanzong pill (WZYZP) is a traditional Chinese medicine prescription that shows efficacy in kidney reinforcement and essence benefit to ameliorate male reproductive dysfunctions. However, the pharmacological mechanisms of the WZYZP on male infertility have not been investigated and clarified clearly. This study was designed to investigate the effects of the WZYZP on spermatogenesis disorder and explore its underlying pharmacological mechanisms. First, based on a network pharmacology study, 39 bioactive compounds and 40 targets of the WZYZP associated with spermatogenesis disorder were obtained, forming a tight compound-target network. Molecular docking tests showed tight docking of these compounds with predicted targeted proteins. The protein-protein interaction (PPI) network identified TP53, TNF, AKT1, Bcl-XL, Bcl-2, and IκBA as hub targets. The Kyoto Encyclopedia of Genes and Genomes pathway network and pathway-target-compound network revealed that the apoptosis pathway was enriched by multiple signaling pathways and multiple targets, including the hub targets. Subsequently, the chemical characterization of WZYZP was analyzed using liquid chromatography to quadrupole/time-of-flight mass spectrometry, and 40 compounds in positive ion mode and 41 compounds in negative ion mode in the WZYZP were identified. Furthermore, based on the prediction of a network pharmacology study, a rat model of spermatogenesis disorder was established to evaluate the curative role and underlying mechanisms of the WZYZP. The results showed that WZYZP treatment improved rat sperm quality and attenuated serum hormone levels, reversed histopathological damage of the testis, reduced cell apoptosis in testis tissues, and ameliorated the expression of the predicted hub targets (TP53, TNF-α, AKT1, NFκB, and IκBA) and the apoptosis related proteins (Bcl-XL, Bcl-2, Bax, Caspase 3, and Caspase 9). These results indicated that the WZYZP has a protective effect on spermatogenesis disorder, suggesting that it could be an alternative choice for male infertility therapy.
ABSTRACT
Erectile dysfunction (ED) is one of the significant complications of diabetes mellitus (DM), and CASR plays an important role in cellular antiapoptosis and NO production in the vascular endothelium by activating PKC. The present study was aimed to investigate the efficacy of Leech and Centipede Granules (LCG) through the CaSR/PLC/PKC signaling. Fifty male Sprague-Dawley rats were treated with streptozotocin to induce the DM model. After 10 weeks, an apomorphine test was used to confirm DMED. Rats with DMED were administrated with LCG and U73122 for 4 weeks. Fasting blood glucose, body weight, insulin and glucagon levels were measured. Erectile function in rats was assessed by apomorphine. Serums were measured using enzyme-linked immunosorbent assay and flow cytometry, and penile tissues were harvested for histologic and the expression of related targets analyses. After treatment, fasting blood glucose, body weight, insulin, glucagon levels, and erectile function were significantly ameliorated in the LCG groups. The LOX-1, NOX, and EMPs concentrations were significantly decreased with LCG treatment. LCG also continuously increased NO and decreased ET-1 content in penile tissues. LCG and U73122 administration also improved penile fibrosis by significantly decreasing VCAM-1, ICAM-1, and CD62P. The data also showed that LCG reduced the apoptosis level in the penis. Furthermore, the inhibited activation of the CaSR/PLC/PKC pathway was observed in DMED rats with LCG treatment. Collectively, LCG significantly ameliorated erectile function of DMED rats via increased NO generation, inhibiting endothelial cells apoptosis and penile fibrosis, which might benefit from the suppression of CaSR/PLC/PKC pathway in DMED rats.
Subject(s)
Diabetes Mellitus, Experimental/complications , Endothelial Cells/drug effects , Impotence, Vasculogenic/drug therapy , Penile Erection/drug effects , Penis/blood supply , Protein Kinase C/metabolism , Receptors, Calcium-Sensing/metabolism , Tissue Extracts/pharmacology , Type C Phospholipases/metabolism , Animals , Apoptosis/drug effects , Apoptosis Regulatory Proteins/metabolism , Diabetes Mellitus, Experimental/chemically induced , Endothelial Cells/enzymology , Endothelial Cells/pathology , Fibrosis , Impotence, Vasculogenic/enzymology , Impotence, Vasculogenic/etiology , Impotence, Vasculogenic/physiopathology , Male , Medicine, Chinese Traditional , Nitric Oxide/metabolism , Nitric Oxide Synthase Type III/metabolism , Rats, Sprague-Dawley , Signal Transduction , Streptozocin , Tissue Extracts/therapeutic useABSTRACT
Complexing capacity (CC) is an important indicator affecting the environmental behavior of heavy metals in water, which can be determined by different methods based on different mechanisms. To validate and compare the applicability of different methods in CC determination, the complexing capacity of Cu2+ (CuCC) in solutions of ethylenediamine tetraacetic acid (EDTA) and acesulfame was determined by methods of dithizone extraction kinetics (DEK) and ion-selective electrodes (ISE), while EDTA and acesulfame were selected to represent strong and weak ligands in water, respectively. DEK method was found to be more suitable for determining the contribution of strong ligands to CuCC, while the results determined by ISE were related to both the strong and weak ligands in water. DEK and ISE methods were used to measure CuCC of several actual water samples, including samples from reservoir, discharge river, fishpond, and landfill leachates. CuCC in the water samples of the reservoir and discharge river measured by ISE were 86.9-227.0 µmol·L-1, which were about one order of magnitude higher than those measured by DEK (9.9-14.6 µmol·L-1). For the landfill leachates, CuCC measured by ISE were 6998.4-31005.8 µmol·L-1, which were 2 orders of magnitude higher than those by DEK (89.6-109.1 µmol·L-1). The increase of CuCC in the polluted water samples might be due to the weak ligands like pollutants. A positive correlation (R=0.975, P<0.01) was found between the CuCC related to the weak ligands (ΔCuCC) and the sum concentration of ammonia nitrogen and organic nitrogen in waters.